The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction.EBI
Weill Cornell Medicine
Structure-Based Rational Design of Constrained Peptides as TIM-3 Inhibitors.EBI
Weill Cornell Medicine
Discovery of Small-Molecule TIM-3 Inhibitors for Acute Myeloid Leukemia Using Pharmacophore-Based Virtual Screening.EBI
Weill Cornell Medicine
Structure-Activity Relationship Studies of Antimalarial EBI
Weill Cornell Medicine
Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit.EBI
Weill Cornell Medicine
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors.EBI
Weill Cornell Medicine
Macrocyclic Peptides that Selectively Inhibit the EBI
Weill Cornell Medicine
Structure-Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides.EBI
Weill Cornell Medicine
Selective Phenylimidazole-Based Inhibitors of the EBI
Weill Cornell Medicine
Improvement of Asparagine Ethylenediamines as Anti-malarial EBI
Weill Cornell Medicine
Novel, Self-Assembling Dimeric Inhibitors of Human β Tryptase.EBI
Weill Cornell Medicine